144 related articles for article (PubMed ID: 34360986)
41. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.
Baldanti F; Lilleri D; Campanini G; Comolli G; Ridolfo AL; Rusconi S; Gerna G
J Antimicrob Chemother; 2004 Mar; 53(3):536-9. PubMed ID: 14739146
[TBL] [Abstract][Full Text] [Related]
42. High CXCL-16 levels correlate with symptomatic disease in lung transplant recipients with human cytomegalovirus replication in the allograft.
Weseslindtner L; Görzer I; Küng E; Roedl K; Jaksch P; Klepetko W; Puchhammer-Stöckl E
Am J Transplant; 2014 Oct; 14(10):2406-11. PubMed ID: 25146250
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
44. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients.
Kotsimbos AT; Sinickas V; Glare EM; Esmore DS; Snell GI; Walters EH; Williams TJ
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1241-6. PubMed ID: 9351628
[TBL] [Abstract][Full Text] [Related]
45. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
[TBL] [Abstract][Full Text] [Related]
46. Relationship between T-cell receptor beta chain sequences and human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
Wu Z; Zhang H; Jin M; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Fan J
Mol Med Rep; 2017 Jun; 15(6):3898-3904. PubMed ID: 28440401
[TBL] [Abstract][Full Text] [Related]
47. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.
Bauer CC; Jaksch P; Aberle SW; Haber H; Lang G; Klepetko W; Hofmann H; Puchhammer-Stöckl E
J Clin Microbiol; 2007 Feb; 45(2):324-8. PubMed ID: 17151208
[TBL] [Abstract][Full Text] [Related]
48. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
49. Human cytomegalovirus strain diversity and dynamics reveal the donor lung as a major contributor after transplantation.
Külekci B; Schwarz S; Brait N; Perkmann-Nagele N; Jaksch P; Hoetzenecker K; Puchhammer-Stöckl E; Goerzer I
Virus Evol; 2022; 8(2):veac076. PubMed ID: 36128049
[TBL] [Abstract][Full Text] [Related]
50. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
[TBL] [Abstract][Full Text] [Related]
51. High incidence of clinically significant cytomegalovirus infection in CMV D+/R+ lung transplant recipients receiving 3 months of antiviral prophylaxis.
Kabbani D; Hirji A; Hernandez C; Malhi H; Mabilangan C; Chandrarathne S; Halloran K; Weinkauf J; Kapasi A; Lien D; Preiksaitis J; Cervera C
Transpl Infect Dis; 2019 Aug; 21(4):e13094. PubMed ID: 30985048
[TBL] [Abstract][Full Text] [Related]
52. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.
Gerna G; Vitulo P; Rovida F; Lilleri D; Pellegrini C; Oggionni T; Campanini G; Baldanti F; Revello MG
J Med Virol; 2006 Mar; 78(3):408-16. PubMed ID: 16419110
[TBL] [Abstract][Full Text] [Related]
53. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
54. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
Mabilangan C; Preiksaitis J; Cervera C;
Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
[TBL] [Abstract][Full Text] [Related]
55. Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.
Lollinga WT; de Wit RH; Rahbar A; Vasse GF; Davoudi B; Diepstra A; Riezebos-Brilman A; Harmsen MC; Hillebrands JL; Söderberg-Naucler C; van Son WJ; Smit MJ; Sanders JS; van den Born J
Transplantation; 2017 Mar; 101(3):531-540. PubMed ID: 27362315
[TBL] [Abstract][Full Text] [Related]
56. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.
Kauvar LM; Liu K; Park M; DeChene N; Stephenson R; Tenorio E; Ellsworth SL; Tabata T; Petitt M; Tsuge M; Fang-Hoover J; Adler SP; Cui X; McVoy MA; Pereira L
Antimicrob Agents Chemother; 2015 Mar; 59(3):1558-68. PubMed ID: 25534746
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
[TBL] [Abstract][Full Text] [Related]
58. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
Schlott F; Steubl D; Hoffmann D; Matevossian E; Lutz J; Heemann U; Hösel V; Busch DH; Renders L; Neuenhahn M
PLoS One; 2017; 12(1):e0171035. PubMed ID: 28129395
[TBL] [Abstract][Full Text] [Related]
59. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
60. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
